NASDAQ : NGNE
Neurogene Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 27.55 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 551.31M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports